These findings favour further study to elucidate the role of E‐selectin in the pathogenesis of NAFLD and the applicability of sE‐selectin as a plasma biomarker of NAFLD/NASH. The gene discussed is SELE; the disease is metabolic dysfunction-associated steatotic liver disease.